"Improving diagnosis of celiac disease"
It was with great success that the 9th International Congress on Autoimmunity was held in Nice from the 26th to 30th of March 2014. More than 2100 participants from over 80 countries used this meeting as an opportunity to share their latest knowledge in all autoimmune-related topics.
As a major sponsor of the congress AESKU.DIAGNOSTICS again showed its close association both to science and to the autoimmune network.
In the Opening Ceremony AESKU.DIAGNOSTICS awarded the AESKU.Award, for the sixth time, to three renowned researchers who have dedicated their life to autoimmunity: Prof. Pier Luigi Meroni from Italy, Dr. Marvin J. Fritzler from Canada and Claire Dwoskin from the United States.
The following 4 days were packed with scientific exchange, interesting lectures and discussions. The sessions, covering a wide range of autoimmune and related disorders, showed the current progress of research into these debilitating diseases. Furthermore, many novel and so far “rare” conditions, even for the field of autoimmune diseases, were discussed. A trend towards multi-parametric diagnosis followed by a tailored therapeutic approach for the needs of each patient was evident throughout the conference proceedings.
In four posters and three lectures our scientists presented the results of their current research. The AESKU posters covered different fields in autoimmunity including automation, vasculitis, lyme arthritis and celiac disease.
The session “The Diagnostic Aspects of Celiac Disease” started with a talk from Dr. Torsten Matthias in which he raised the question of microbial transglutaminase being a key player of celiac disease. The following presentation from Patricia Jeremias reviewed the results of 12 years anti-neo-epitope antibody testing in CD.
One of the outstanding topics of this meeting was the increasing automation of indirect immunofluorescence diagnostics. In the session “Antinuclear Antibodies (ANA) Immunofluorescence” many presentations showed the unique value of the HELIOS® IFA processor and reader. Moreover, in the session “Novelties in autoimmunity”, Bruno Larida compared in his presentation the HELIOS® with another ANA screening method.
During the breaks, the accompanying exhibition provided meeting participants with the opportunity to gain an impression of the instrument. Across 3 booths, prospective customers could extend their knowledge of the HELIOS®. Moreover, the new HELMED® Blot-Module was met with broad interest. Both instruments - the HELIOS® and the HELMED® - showed that automation is still an important topic in the routine autoimmune lab.
Overall, the 9th International Congress on Autoimmunity was a great success for AESKU and a starting point for many pioneering projects.